Overview Insulin Glargine in Type 2 Diabetes Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The aim of this project is to confirm the efficacy and safety profile of Insulin glargine in daily practice and to improve the physicians' knowledge and experience concerning Insulin glargine Phase: Phase 4 Details Lead Sponsor: SanofiTreatments: InsulinInsulin GlargineInsulin, Globin Zinc